“Altered threonine tyrosine kinase (TTK) expression is associated with adverse clinical outcomes in breast tumors: An in silico approach”, RSD, vol. 12, no. 13, p. e40121344285, Nov. 2023, doi: 10.33448/rsd-v12i13.44285.